Skip to content
The Policy VaultThe Policy Vault

Linzess (linaclotide)United Healthcare

functional constipation

Initial criteria

  • Diagnosis of chronic idiopathic constipation OR
  • Diagnosis of irritable bowel syndrome with constipation OR
  • Diagnosis of functional constipation

Reauthorization criteria

  • Documentation of positive clinical response to therapy

Approval duration

12 months